Disclaimer:

Medidex is not a provider of medical services and all information is provided for the convenience of the user. No medical decisions should be made based on the information provided on this website without first consulting a licensed healthcare provider.This website is intended for persons 18 years or older. No person under 18 should consult this website without the permission of a parent or guardian.

Eurax

×

Overview

What is Eurax?

Eurax (crotamiton, USP) is a scabicidal and antipruritic agent available as a cream or lotion for topical use only. Eurax provides 10% (w/w) of the synthetic, crotamiton, USP, in a vanishing-cream or emollient-lotion base containing: carbomer-934, cetyl alcohol, diazolidinylurea, dimethicone, fragrance, laureth-23, magnesium aluminum silicate, magnesium nitrate, methylchloroisothiazolinone, methylisothiazolinone, petrolatum, propylene glycol, sodium hydroxide, steareth-2, and water. In addition, the cream contains glyceryl stearate.

Crotamiton is N-ethyl-N-(-methylphenyl)-2-butenamide and its structural formula is:

Crotamiton, USP is a colorless to slightly yellowish oil, having a faint amine-like odor. It is miscible with alcohol and with methanol. Crotamiton is a mixture of the and isomers. Its molecular weight is 203.28.



What does Eurax look like?



What are the available doses of Eurax?

Sorry No records found.

What should I talk to my health care provider before I take Eurax?

Sorry No records found

How should I use Eurax?

For eradication of scabies and for symptomatic treatment of pruritic skin.

In Scabies:

In Pruritus:

LOTION: Shake well before using.


What interacts with Eurax?

Eurax should not be applied topically to patients who develop a sensitivity or are allergic to it or who manifest a primary irritation response to topical medications.



What are the warnings of Eurax?

If CDAD is suspected or confirmed, ongoing antibiotic use not directed against may need to be discontinued. Appropriate fluid and electrolyte management, protein supplementation, antibiotic treatment of and surgical evaluation should be instituted as clinically indicated.


What are the precautions of Eurax?

General

Eurax should not be applied in the eyes or mouth because it may cause irritation. It should not be applied to acutely inflamed skin or raw or weeping surfaces until the acute inflammation has subsided.

Information for Patients

See

Drug Interactions

None known.

Carcinogenesis and Mutagenesis and Impairment of Fertility

Long-term carcinogenicity studies in animals have not been conducted.

Pregnancy (Category C)

Animal reproduction studies have not been conducted with Eurax. It is also not known whether Eurax can cause fetal harm when applied topically to a pregnant woman or can affect reproduction capacity. Eurax should be given to a pregnant woman only if clearly needed.

Pediatric Use

Safety and effectiveness in pediatric patients have not been established.

Geriatric Use

Clinical studies with Eurax (crotamiton, USP) Lotion/Cream did not include sufficient numbers of subjects aged 65 years and older to determine whether they respond differently than younger subjects. Other reported clinical experience has not identified differences in responses between elderly and younger patients, but greater sensitivity of some older individuals cannot be ruled out.


What are the side effects of Eurax?

Primary irritation reactions, such as dermatitis, pruritus, and rash, and allergic sensitivity reactions have been reported in a few patients.


What should I look out for while using Eurax?

Eurax should not be applied topically to patients who develop a sensitivity or are allergic to it or who manifest a primary irritation response to topical medications.

If severe irritation or sensitization develops, treatment with this product should be discontinued and appropriate therapy instituted.


What might happen if I take too much Eurax?

There is no specific information on the effect of overtreatment with repeated topical applications in humans. A death was reported but cause was not confirmed.

Accidental oral ingestion may be accompanied by burning sensation in the mouth, irritation of the buccal, esophageal and gastric mucosa, nausea, vomiting, abdominal pain.

If accidental ingestion occurs, call your Poison Control Center.


How should I store and handle Eurax?

Receipt, transfer, handling, possession, or use of this product is subject to the radioactive material regulations and licensing requirements of the U.S. Nuclear Regulatory Commission, Agreement States or Licensing States as appropriate.Eurax® (crotamiton, USP) Cream, 10% is a white to yellowish-white soft cream with a perfumed characteristic odor and supplied as: 60 g tubes NDC 10631-091-60 (NSN 6505-00-116-0200)Eurax® (crotamiton, USP) Lotion, 10% is a white to yellowish-white lotion having a characteristic perfumed odor and supplied as: 60 g (2 oz.) bottle NDC 10631-092-60 (NSN 6505-01-153-4423)454 g (16 oz.) bottle NDC 10631-092-16SHAKE WELL before using.Store at room temperature.Keep out of reach of children.To report SUSPECTED ADVERSE REACTIONS, contact the FDA at 1-800-FDA-1088 or RANBAXYJacksonville, FL 32257 USA129845September 2012Eurax® (crotamiton, USP) Cream, 10% is a white to yellowish-white soft cream with a perfumed characteristic odor and supplied as: 60 g tubes NDC 10631-091-60 (NSN 6505-00-116-0200)Eurax® (crotamiton, USP) Lotion, 10% is a white to yellowish-white lotion having a characteristic perfumed odor and supplied as: 60 g (2 oz.) bottle NDC 10631-092-60 (NSN 6505-01-153-4423)454 g (16 oz.) bottle NDC 10631-092-16SHAKE WELL before using.Store at room temperature.Keep out of reach of children.To report SUSPECTED ADVERSE REACTIONS, contact the FDA at 1-800-FDA-1088 or RANBAXYJacksonville, FL 32257 USA129845September 2012Eurax® (crotamiton, USP) Cream, 10% is a white to yellowish-white soft cream with a perfumed characteristic odor and supplied as: 60 g tubes NDC 10631-091-60 (NSN 6505-00-116-0200)Eurax® (crotamiton, USP) Lotion, 10% is a white to yellowish-white lotion having a characteristic perfumed odor and supplied as: 60 g (2 oz.) bottle NDC 10631-092-60 (NSN 6505-01-153-4423)454 g (16 oz.) bottle NDC 10631-092-16SHAKE WELL before using.Store at room temperature.Keep out of reach of children.To report SUSPECTED ADVERSE REACTIONS, contact the FDA at 1-800-FDA-1088 or RANBAXYJacksonville, FL 32257 USA129845September 2012Eurax® (crotamiton, USP) Cream, 10% is a white to yellowish-white soft cream with a perfumed characteristic odor and supplied as: 60 g tubes NDC 10631-091-60 (NSN 6505-00-116-0200)Eurax® (crotamiton, USP) Lotion, 10% is a white to yellowish-white lotion having a characteristic perfumed odor and supplied as: 60 g (2 oz.) bottle NDC 10631-092-60 (NSN 6505-01-153-4423)454 g (16 oz.) bottle NDC 10631-092-16SHAKE WELL before using.Store at room temperature.Keep out of reach of children.To report SUSPECTED ADVERSE REACTIONS, contact the FDA at 1-800-FDA-1088 or RANBAXYJacksonville, FL 32257 USA129845September 2012Eurax® (crotamiton, USP) Cream, 10% is a white to yellowish-white soft cream with a perfumed characteristic odor and supplied as: 60 g tubes NDC 10631-091-60 (NSN 6505-00-116-0200)Eurax® (crotamiton, USP) Lotion, 10% is a white to yellowish-white lotion having a characteristic perfumed odor and supplied as: 60 g (2 oz.) bottle NDC 10631-092-60 (NSN 6505-01-153-4423)454 g (16 oz.) bottle NDC 10631-092-16SHAKE WELL before using.Store at room temperature.Keep out of reach of children.To report SUSPECTED ADVERSE REACTIONS, contact the FDA at 1-800-FDA-1088 or RANBAXYJacksonville, FL 32257 USA129845September 2012Eurax® (crotamiton, USP) Cream, 10% is a white to yellowish-white soft cream with a perfumed characteristic odor and supplied as: 60 g tubes NDC 10631-091-60 (NSN 6505-00-116-0200)Eurax® (crotamiton, USP) Lotion, 10% is a white to yellowish-white lotion having a characteristic perfumed odor and supplied as: 60 g (2 oz.) bottle NDC 10631-092-60 (NSN 6505-01-153-4423)454 g (16 oz.) bottle NDC 10631-092-16SHAKE WELL before using.Store at room temperature.Keep out of reach of children.To report SUSPECTED ADVERSE REACTIONS, contact the FDA at 1-800-FDA-1088 or RANBAXYJacksonville, FL 32257 USA129845September 2012Eurax® (crotamiton, USP) Cream, 10% is a white to yellowish-white soft cream with a perfumed characteristic odor and supplied as: 60 g tubes NDC 10631-091-60 (NSN 6505-00-116-0200)Eurax® (crotamiton, USP) Lotion, 10% is a white to yellowish-white lotion having a characteristic perfumed odor and supplied as: 60 g (2 oz.) bottle NDC 10631-092-60 (NSN 6505-01-153-4423)454 g (16 oz.) bottle NDC 10631-092-16SHAKE WELL before using.Store at room temperature.Keep out of reach of children.To report SUSPECTED ADVERSE REACTIONS, contact the FDA at 1-800-FDA-1088 or RANBAXYJacksonville, FL 32257 USA129845September 2012Eurax® (crotamiton, USP) Cream, 10% is a white to yellowish-white soft cream with a perfumed characteristic odor and supplied as: 60 g tubes NDC 10631-091-60 (NSN 6505-00-116-0200)Eurax® (crotamiton, USP) Lotion, 10% is a white to yellowish-white lotion having a characteristic perfumed odor and supplied as: 60 g (2 oz.) bottle NDC 10631-092-60 (NSN 6505-01-153-4423)454 g (16 oz.) bottle NDC 10631-092-16SHAKE WELL before using.Store at room temperature.Keep out of reach of children.To report SUSPECTED ADVERSE REACTIONS, contact the FDA at 1-800-FDA-1088 or RANBAXYJacksonville, FL 32257 USA129845September 2012Eurax® (crotamiton, USP) Cream, 10% is a white to yellowish-white soft cream with a perfumed characteristic odor and supplied as: 60 g tubes NDC 10631-091-60 (NSN 6505-00-116-0200)Eurax® (crotamiton, USP) Lotion, 10% is a white to yellowish-white lotion having a characteristic perfumed odor and supplied as: 60 g (2 oz.) bottle NDC 10631-092-60 (NSN 6505-01-153-4423)454 g (16 oz.) bottle NDC 10631-092-16SHAKE WELL before using.Store at room temperature.Keep out of reach of children.To report SUSPECTED ADVERSE REACTIONS, contact the FDA at 1-800-FDA-1088 or RANBAXYJacksonville, FL 32257 USA129845September 2012Eurax® (crotamiton, USP) Cream, 10% is a white to yellowish-white soft cream with a perfumed characteristic odor and supplied as: 60 g tubes NDC 10631-091-60 (NSN 6505-00-116-0200)Eurax® (crotamiton, USP) Lotion, 10% is a white to yellowish-white lotion having a characteristic perfumed odor and supplied as: 60 g (2 oz.) bottle NDC 10631-092-60 (NSN 6505-01-153-4423)454 g (16 oz.) bottle NDC 10631-092-16SHAKE WELL before using.Store at room temperature.Keep out of reach of children.To report SUSPECTED ADVERSE REACTIONS, contact the FDA at 1-800-FDA-1088 or RANBAXYJacksonville, FL 32257 USA129845September 2012Eurax® (crotamiton, USP) Cream, 10% is a white to yellowish-white soft cream with a perfumed characteristic odor and supplied as: 60 g tubes NDC 10631-091-60 (NSN 6505-00-116-0200)Eurax® (crotamiton, USP) Lotion, 10% is a white to yellowish-white lotion having a characteristic perfumed odor and supplied as: 60 g (2 oz.) bottle NDC 10631-092-60 (NSN 6505-01-153-4423)454 g (16 oz.) bottle NDC 10631-092-16SHAKE WELL before using.Store at room temperature.Keep out of reach of children.To report SUSPECTED ADVERSE REACTIONS, contact the FDA at 1-800-FDA-1088 or RANBAXYJacksonville, FL 32257 USA129845September 2012Eurax® (crotamiton, USP) Cream, 10% is a white to yellowish-white soft cream with a perfumed characteristic odor and supplied as: 60 g tubes NDC 10631-091-60 (NSN 6505-00-116-0200)Eurax® (crotamiton, USP) Lotion, 10% is a white to yellowish-white lotion having a characteristic perfumed odor and supplied as: 60 g (2 oz.) bottle NDC 10631-092-60 (NSN 6505-01-153-4423)454 g (16 oz.) bottle NDC 10631-092-16SHAKE WELL before using.Store at room temperature.Keep out of reach of children.To report SUSPECTED ADVERSE REACTIONS, contact the FDA at 1-800-FDA-1088 or RANBAXYJacksonville, FL 32257 USA129845September 2012Eurax® (crotamiton, USP) Cream, 10% is a white to yellowish-white soft cream with a perfumed characteristic odor and supplied as: 60 g tubes NDC 10631-091-60 (NSN 6505-00-116-0200)Eurax® (crotamiton, USP) Lotion, 10% is a white to yellowish-white lotion having a characteristic perfumed odor and supplied as: 60 g (2 oz.) bottle NDC 10631-092-60 (NSN 6505-01-153-4423)454 g (16 oz.) bottle NDC 10631-092-16SHAKE WELL before using.Store at room temperature.Keep out of reach of children.To report SUSPECTED ADVERSE REACTIONS, contact the FDA at 1-800-FDA-1088 or RANBAXYJacksonville, FL 32257 USA129845September 2012


×

Clinical Information

Chemical Structure

No Image found
Clinical Pharmacology

Eurax has scabicidal and antipruritic actions. The mechanisms of these actions are not known. The pharmacokinetics of crotamiton and its degree of systemic absorption following topical application have not been determined.

Non-Clinical Toxicology
Eurax should not be applied topically to patients who develop a sensitivity or are allergic to it or who manifest a primary irritation response to topical medications.

If severe irritation or sensitization develops, treatment with this product should be discontinued and appropriate therapy instituted.

None known.

Eurax should not be applied in the eyes or mouth because it may cause irritation. It should not be applied to acutely inflamed skin or raw or weeping surfaces until the acute inflammation has subsided.

Primary irritation reactions, such as dermatitis, pruritus, and rash, and allergic sensitivity reactions have been reported in a few patients.

×

Reference

This information is obtained from the National Institute of Health's Standard Packaging Label drug database.
"https://dailymed.nlm.nih.gov/dailymed/"

While we update our database periodically, we cannot guarantee it is always updated to the latest version.

×

Review

Rate this treatment and share your opinion


Learn about User Reviews

Helpful tips to write a good review:

  1. Only share your first hand experience as a consumer or a care giver.
  2. Describe your experience in the Comments area including the benefits, side effects and how it has worked for you. Do not provide personal information like email addresses or telephone numbers.
  3. Fill in the optional information to help other users benefit from your review.

Reason for Taking This Treatment

(required)

Click the stars to rate this treatment

Effectiveness (required)

This medication has worked for me.




Ease of Use (required)

This medication has been easy for me to use.




Satisfaction (required)

Overall, I have been satisfied with my experience.




Write a brief description of your experience with this treatment:

2000 characters remaining

Optional Information

Help others benefit from your review by filling in the information below.
I am a:
Gender:
×

Professional

Clonazepam Description Each single-scored tablet, for oral administration, contains 0.5 mg, 1 mg, or 2 mg Clonazepam, USP, a benzodiazepine. Each tablet also contains corn starch, lactose monohydrate, magnesium stearate, microcrystalline cellulose, and povidone. Clonazepam tablets USP 0.5 mg contain Yellow D&C No. 10 Aluminum Lake. Clonazepam tablets USP 1 mg contain Yellow D&C No. 10 Aluminum Lake, as well as FD&C Blue No. 1 Aluminum Lake. Chemically, Clonazepam, USP is 5-(o-chlorophenyl)-1,3-dihydro-7-nitro-2H-1,4-benzodiazepin-2-one. It is a light yellow crystalline powder. It has the following structural formula: C15H10ClN3O3 M.W. 315.72
×

Tips

Tips

×

Interactions

Interactions

A total of 440 drugs (1549 brand and generic names) are known to interact with Imbruvica (ibrutinib). 228 major drug interactions (854 brand and generic names) 210 moderate drug interactions (691 brand and generic names) 2 minor drug interactions (4 brand and generic names) Show all medications in the database that may interact with Imbruvica (ibrutinib).